PerspectiveMénétrier’s Disease

Ménétrier’s Disease Therapy: Rebooting Mucosal Signaling

Science Translational Medicine  25 Nov 2009:
Vol. 1, Issue 8, pp. 8ps10
DOI: 10.1126/scitranslmed.3000438

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Ménétrier’s disease, a rare hyperproliferative disorder of the stomach, is associated with chronic abdominal pain, vomiting, weight loss, and edema, as well as an increased risk of gastric cancer. Therapy, other than surgical resection of the stomach, is limited to supportive measures and reflects the limited understanding of Ménétrier’s disease pathogenesis. Data reported in this issue describe a promising targeted therapeutic approach and provide new insight into the causes of Ménétrier’s disease.

Footnotes

  • Citation: S. C. Nalle, J. R. Turner, Ménétrier’s disease therapy: Rebooting mucosal signaling. Sci. Transl. Med. 1, 8ps10 (2009).

View Full Text